Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12968/hmed.2020.0284 http://scihub22266oqcxt.onion/10.12968/hmed.2020.0284 32589537!ä!32589537 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Hosp+Med+(Lond) 2020 ; 81 (6): 1-3 Nephropedia Template TP {{tp|p=32589537|t=2020. COVID-19 and rheumatology: is shielding really necessary?|pdf=|usr=}}{{32589537}} gab.com Text COVID-19 and rheumatology: is shielding really necessary JO: Br J Hosp Med (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=32589537 #FOAvip Rheumatology patients who are taking immunosuppressants are considered to be at 'high risk' from COVID-19, hence have been self-isolating or shielding. However, they may be protected from the features of hyperinflammation driven by a 'cytokine storm', so may have better clinical outcomes if infected. This editorial discusses whether it may not be necessary to advise these patients to shield. Twit Text FOAVip COVID-19 and rheumatology: is shielding really necessary ????Br J Hosp Med (Lond) http://www.kidney.de/pget.php?&tw=1&pmid=32589537 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32589537 #FOAvip English Wikipedia <ref>{{Cite pmid|32589537}}</ref> COVID-19 and rheumatology: is shielding really necessary? #MMPMID32589537 Amani L; Warraich R; Patel N; Tahir H Br J Hosp Med (Lond) 2020[Jun]; 81 (6): 1-3 PMID32589537show ga Rheumatology patients who are taking immunosuppressants are considered to be at 'high risk' from COVID-19, hence have been self-isolating or shielding. However, they may be protected from the features of hyperinflammation driven by a 'cytokine storm', so may have better clinical outcomes if infected. This editorial discusses whether it may not be necessary to advise these patients to shield. |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/immunology/physiopathology/*prevention & control[MESH] |Cytokine Release Syndrome/etiology/immunology/physiopathology[MESH] |Health Behavior[MESH] |Humans[MESH] |Immunosuppressive Agents/*therapeutic use[MESH] |Pandemics/*prevention & control[MESH] |Patient Education as Topic[MESH] |Pneumonia, Viral/complications/immunology/physiopathology/*prevention & control[MESH] |Protective Factors[MESH] |Rheumatic Diseases/*drug therapy[MESH] |Rheumatology[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]COVID-19 and rheumatology: is shielding really necessary?(epmc).pdf DeepDyve Pubget Overpricing